A meta-analysis showed that Gal-9 expression was associated with a favorable prognosis in both hepatocellular carcinoma and colorectal carcinoma, but also other characteristics, such as disease stage and the presence of lymph node metastasis 23. The gene discussed is LGALS9; the disease is metastatic malignant neoplasm in the lymph nodes.